1. Home
  2. CNOB vs ABCL Comparison

CNOB vs ABCL Comparison

Compare CNOB & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ConnectOne Bancorp Inc.

CNOB

ConnectOne Bancorp Inc.

HOLD

Current Price

$27.43

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.20

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNOB
ABCL
Founded
1982
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
CNOB
ABCL
Price
$27.43
$4.20
Analyst Decision
Buy
Buy
Analyst Count
2
5
Target Price
$29.50
$7.75
AVG Volume (30 Days)
252.2K
4.2M
Earning Date
01-30-2026
02-26-2026
Dividend Yield
2.74%
N/A
EPS Growth
N/A
N/A
EPS
1.30
N/A
Revenue
$295,956,000.00
$35,325,000.00
Revenue This Year
$47.80
$25.45
Revenue Next Year
$31.81
$10.07
P/E Ratio
$20.23
N/A
Revenue Growth
19.03
7.17
52 Week Low
$20.61
$1.89
52 Week High
$28.47
$6.52

Technical Indicators

Market Signals
Indicator
CNOB
ABCL
Relative Strength Index (RSI) 60.15 58.74
Support Level $25.78 $4.08
Resistance Level $26.95 $4.66
Average True Range (ATR) 0.62 0.26
MACD -0.05 0.09
Stochastic Oscillator 90.64 64.77

Price Performance

Historical Comparison
CNOB
ABCL

About CNOB ConnectOne Bancorp Inc.

ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: